Endologix today announced that it has launched its Alto abdominal stent graft system in Europe.
The first implant of the stent graft took place in Stevenage, England, following the company’s recent CE mark approval. The device was chosen for that specific patient because of their short, thrombus-lined conical aortic neck.
“We are pleased to expand the product launch to include Europe, making Alto available to our physician partners and patients there as well as in the U.S.,” chief medical officer Matt Thompson said in a news release. “Alto offers a highly differentiated endovascular treatment option for AAA patients and includes design features that we believe will enhance ease-of-use, improve acute outcomes and preserve the long-term durability associated with patient-specific anatomically adaptive sealing.”
The Alto Abdominal Stent Graft System is an Ovation system for polymer endovascular aneurysm repair. It first received FDA approval in March this year.
